» Articles » PMID: 15850472

Apoptotic Cytokeratin 18 Neoepitopes in Serum of Patients with Chronic Hepatitis C

Overview
Journal J Viral Hepat
Specialty Gastroenterology
Date 2005 Apr 27
PMID 15850472
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with chronic hepatitis C, alanine aminotransferase (ALT) levels do not accurately reflect the extent of liver inflammation. The discrepancy between ALT level and liver damage could be related to the mode of cell death. In the present study, we quantified serum levels of apoptotic cytokeratin 18 (CK-18) neoepitopes that are generated by activated caspases during apoptosis. Apoptotic CK-18 neoepitopes were quantified by enzyme linked immunosorbent assay in sera from patients with chronic hepatitis C and elevated ALT levels (n = 72), patients with chronic hepatitis C and persistently normal ALT levels (n = 27) and healthy controls (n = 19). Serum CK-18 neoepitope levels were strongly correlated with ALT (r = 0.659, P < 0.0001) and the histology activity index (r = 0.374, P < 0.001). Patients with chronic hepatitis C and persistently normal ALT levels had higher apoptotic CK-18 neoepitope levels than healthy controls (P = 0.03) but lower levels than patients with chronic hepatitis C and elevated ALT levels (P < 0.001). Highest serum CK-18 neoepitope levels were observed in patients with cirrhosis (P = 0.002). Hence apoptotic CK-18 neoepitopes in serum of patients with chronic hepatitis C are associated with ALT level and histological liver damage. Serum apoptotic CK-18 neoepitope levels are elevated both in patients with chronic hepatitis C and elevated ALT levels as well as in patients with normal ALT levels indicating that also patients with chronic hepatitis C and normal ALT have an increased hepatocyte loss by apoptosis.

Citing Articles

Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis.

Hildenbrand F, Illi B, von Felten S, Bachofner J, Gawinecka J, von Eckardstein A BMC Gastroenterol. 2024; 24(1):54.

PMID: 38291388 PMC: 10825988. DOI: 10.1186/s12876-023-03116-4.


Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery.

Hempel F, Roderfeld M, Muntnich L, Albrecht J, Oruc Z, Arneth B J Clin Med. 2021; 10(6).

PMID: 33809676 PMC: 8002276. DOI: 10.3390/jcm10061233.


Autophagy alleviates amiodarone-induced hepatotoxicity.

Wandrer F, Frangez Z, Liebig S, John K, Vondran F, Wedemeyer H Arch Toxicol. 2020; 94(10):3527-3539.

PMID: 32651653 PMC: 7502042. DOI: 10.1007/s00204-020-02837-9.


Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives.

Fu S, Wu D, Jiang W, Li J, Long J, Jia C Front Pharmacol. 2020; 10:1667.

PMID: 32082163 PMC: 7002317. DOI: 10.3389/fphar.2019.01667.


Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis.

Ismail S, El Saadany S, Ziada D, Zakaria S, Mayah W, Elashry H Asian Pac J Cancer Prev. 2017; 18(4):1105-1111.

PMID: 28547948 PMC: 5494222. DOI: 10.22034/APJCP.2017.18.4.1105.